15 Results for "

GH3

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "GH3" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-101422
CAS No.: 1380341-99-0
Purity:  99.93%
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

GAL-021 is a potent BKCa-channel blocker. GAL-021 inhibits KCa1.1 in GH3 cells. GAL-021 is a novel breathing control modulator that is based on selective modification of the almitrine pharmacophore. GAL-021 increases minute ventilation in rats and non-human primates .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1462
CAS No.: 95-25-0
Chlorzoxazone is a SK-type potassium channel activator. Chlorzoxazone modulates FOXO3 phosphorylation and . Chlorzoxazone enhances immunosuppression, attenuates vasoconstriction, attenuates cognitive deficits, and improves experimental autoimmune encephalomyelitis [3] .
loading...
    loading...
Cat. No.: HY-P1959
CAS No.: 108736-35-2
Synonyms: BIM 23014
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology Cancer

Lanreotide (BIM 23014) is a somatostatin analogue with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome .
loading...
    loading...
Cat. No.: HY-P1959A
CAS No.: 2378114-72-6
Synonyms: BIM 23014 acetate
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology Cancer

Lanreotide (BIM 23014) acetate is a somatostatin analogue with antineoplastic activity. Lanreotide acetate can be used for the research of carcinoid syndrome .
loading...
    loading...
Cat. No.: HY-114557
CAS No.: 1041-01-6
Purity:  99.38%
Synonyms: 3,5-Diiodo-L-thyronine
NSC 90469 (3,5-Diiodo-L-thyronine) is an orally active thyroid hormone derivative. NSC 90469 inhibits JNK phosphorylation and NF-κB acetylation, blocks SIRT1 protein expression, induces elevated PGC-1α levels, and stimulates COX activity. NSC 90469 enhances UCP1-mediated thermogenesis, increases hepatic Dio1 activity, inhibits TSH levels and hypothalamic-pituitary-thyroid axis function, enhances lipid metabolism, and regulates energy metabolism via the mitochondrial pathway. NSC 90469 prevents blood glucose reduction, reduces urinary albumin excretion, inhibits renal matrix expansion, decreases TGF-β1 expression, and reduces renal fibronectin and type Ⅳ collagen deposition. NSC 90469 also increases energy expenditure and prevents diet-induced overweight. NSC 90469 can be used in studies related to diabetic nephropathy, hypothyroidism, non-alcoholic fatty liver disease, and diet-induced obesity [3] .
loading...
    loading...
Cat. No.: HY-P1104A
CAS No.: 842166-42-1
Target:  

CXCR Akt Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

FC131 TFA is a CXCR4 antagonist that inhibits AKT kinase activity in AML OCI-AML3 cells. D-ArgFC131, a derivative of FC131 TFA, inhibits the phosphorylation of downstream ERK1/2 and Akt, induces caspase-3 pathway-mediated apoptosis, and causes cell cycle arrest. FC131 TFA exerts cytotoxic effects in cancer cells such as AML cells. FC131 TFA is applicable for cancer-related research [3].
loading...
    loading...
Cat. No.: HY-149902
CAS No.: 2477651-10-6
Purity:  99.17%
Target:  

Deubiquitinase

Research Areas:  

Cancer

USP8-IN-3 (Compd U51) is a deubiquitinase USP8 inhibitor with an IC50 value of 4.0 μM. USP8-IN-3 also inhibits the proliferation of GH3 and H1957 cells with GI50s of 37.03 μM and 6.01 μM, respectively .
loading...
    loading...
Cat. No.: HY-117931
CAS No.: 141797-92-4
Purity:  99.67%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

NS004 is a potassium (BK) channel activator that increases Iberiotoxin (HY-P0190) or Tetraethylammonium (HY-B1793)-sensitive whole-cell efflux currents. NS004 also significantly increased the activity of individual GH3 cell BK channels and rat brain BK channels reorganized into planar lipid bilayers, causing an increase in channel mean open time, a decrease in intermittent time, and an increase in channel voltage/calcium sensitivity .
loading...
    loading...
Cat. No.: HY-108592
CAS No.: 918311-87-2
Purity:  98.91%
UCL 2077 is a potassium channel and slow afterhyperpolarization (sAHP) inhibitor. UCL 2077 selectively blocks sAHP channels without affecting L-type Ca 2+ currents. UCL 2077 blocks KCNQ1- and KCNQ2-containing K + channels, decreases erg current amplitude, increases erg deactivation rate. UCL 2077 can be used for the research of hippocampus-dependent memory retrieval deficit and cardiac arrhythmias [3].
loading...
    loading...
Cat. No.: HY-P1104
CAS No.: 606968-52-9
Target:  

CXCR Akt Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

FC131 is a CXCR4 antagonist that inhibits AKT kinase activity in AML OCI-AML3 cells. D-ArgFC131, a derivative of FC131, inhibits the phosphorylation of downstream ERK1/2 and Akt, induces caspase-3 pathway-mediated apoptosis, and causes cell cycle arrest. FC131 exerts cytotoxic effects in cancer cells such as AML cells. FC131 is applicable for cancer-related research [3].
loading...
    loading...
Cat. No.: HY-101422A
CAS No.: 1380342-00-6
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

GAL-021 sulfate is a potent BKCa-channel blocker. GAL-021 sulfate inhibits KCa1.1 in GH3 cells. GAL-021 sulfate is a novel breathing control modulator that is based on selective modification of the almitrine pharmacophore. GAL-021 sulfate increases minute ventilation in rats and non-human primates .
loading...
    loading...
Cat. No.: HY-130070
CAS No.: 1259536-70-3
Purity:  98.77%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

QO-40, a pyrazolo[1,5-a]pyrimidine-7(4H)-one (PPO) derivative, is a KCNQ2/KCNQ3 K + channels activator with an EC50 of 6.94 μM. QO-40 stimulated Ca 2+-activated K + current (IK(Ca)) with an EC50 value of 2.3 μM in pituitary GH3 lactotrophs .
loading...
    loading...
Cat. No.: HY-101422R
CAS No.: 1380341-99-0
GAL-021 (Standard) is the analytical standard of GAL-021 (HY-101422). This product is intended for research and analytical applications. GAL-021 is a potent BKCa-channel blocker. GAL-021 inhibits KCa1.1 in GH3 cells. GAL-021 is a novel breathing control modulator that is based on selective modification of the almitrine pharmacophore. GAL-021 increases minute ventilation in rats and non-human primates .
loading...
    loading...
Cat. No.: HY-165327
CAS No.: 120755-15-9
Target:  

Phospholipase

Research Areas:  

Inflammation/Immunology

AGN-190383 is a bee venom phospholipase A2 inhibitor. AGN 190383 inhibits both hormone-operated and depolarization-dependent calcium mobilization as well as fMLP stimulated increases in free cytosolic calcium. AGN-190383 has anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-P1959B
CAS No.: 1024499-83-9
Synonyms: BIM 23014 diTFA
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology Cancer

Lanreotide (BIM 23014) diTFA is a somatostatin analogue with antineoplastic activity. Lanreotide diTFA can be used for the research of carcinoid syndrome .
loading...
    loading...
  • 1